273 related articles for article (PubMed ID: 15890740)
1. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.
Pirard C; Donnez J; Loumaye E
Hum Reprod; 2005 Jul; 20(7):1798-804. PubMed ID: 15890740
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
Pirard C; Donnez J; Loumaye E
Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
4. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
5. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
Andersen CY; Humaidan P; Ejdrup HB; Bungum L; Grøndahl ML; Westergaard LG
Hum Reprod; 2006 Aug; 21(8):2126-30. PubMed ID: 16682403
[TBL] [Abstract][Full Text] [Related]
6. Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach.
Garcia-Velasco JA; Motta L; López A; Mayoral M; Cerrillo M; Pacheco A
Fertil Steril; 2010 Dec; 94(7):2820-3. PubMed ID: 20673892
[TBL] [Abstract][Full Text] [Related]
7. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
8. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
Bramley TA; Stirling D; Menzies GS; Baird DT
Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
[TBL] [Abstract][Full Text] [Related]
9. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy rates, LH and progesterone concentrations in mares treated with a GnRH agonist.
Kanitz W; Schneider F; Hoppen HO; Unger C; Nürnberg G; Becker F
Anim Reprod Sci; 2007 Jan; 97(1-2):55-62. PubMed ID: 16488561
[TBL] [Abstract][Full Text] [Related]
11. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
12. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
Mochtar MH; Van Wely M; Van der Veen F
Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
[TBL] [Abstract][Full Text] [Related]
13. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
[TBL] [Abstract][Full Text] [Related]
14. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
Ellenbogen A; David H; Libal Y; Ballas S
Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
[TBL] [Abstract][Full Text] [Related]
15. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
[TBL] [Abstract][Full Text] [Related]
17. The effects of GnRH analogue (buserelin) or hCG (Chorulon) on Day 12 of pregnancy on ovarian function, plasma hormone concentrations, conceptus growth and placentation in ewes and ewe lambs.
Khan TH; Beck NF; Khalid M
Anim Reprod Sci; 2007 Dec; 102(3-4):247-57. PubMed ID: 17174489
[TBL] [Abstract][Full Text] [Related]
18. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
19. GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Engmann L; Benadiva C
Hum Reprod; 2005 Nov; 20(11):3258-60; author reply 3260. PubMed ID: 16246862
[No Abstract] [Full Text] [Related]
20. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women.
Gleicher N; Brown T; Dudkiewicz A; Karande V; Rao R; Balin M; Campbell D; Pratt D
Early Pregnancy (Cherry Hill); 2000 Jan; 4(1):64-73. PubMed ID: 11719823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
